[Retracted] Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Carcinoma: A Real-World Study

Figure 7

DFS curves of luminal B/HER2+ and nonluminal B/HER2+ patients in non-pCR patients administered with trastuzumab.